Literature DB >> 34982362

A case of enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction which was successfully treated with somatostatin analogue.

Ryosuke Hirai1, Ken Haruma2, Hiroyuki Okada3, Junya Itakura4, Motowo Mizuno5.   

Abstract

We report here a case of a 62-year-old woman with multiple gastric enterochromaffin-like cell neuroendocrine tumor caused by hypergastrinemia due to parietal cell dysfunction that was successfully treated with somatostatin analogue. Esophagogastroduodenoscopy revealed several G1 neuroendocrine tumors, 10 mm in diameter, in the body of the stomach. No evidence of autoimmune gastritis, Helicobacter pylori infection, neuroendocrine neoplasia type 1, or Zollinger-Ellison syndrome was identified. The pattern of immunohistochemical staining of the background gastric mucosa was suggestive of parietal cell dysfunction. She was treated with long-acting release octreotide acetate. Complete response was confirmed after 9 months and was maintained for 22 months.
© 2022. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Enterochromaffin-like cell neuroendocrine tumor; Hypergastrinemia; Parietal cell dysfunction; Somatostatin analogue

Mesh:

Substances:

Year:  2022        PMID: 34982362     DOI: 10.1007/s12328-021-01581-6

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  1 in total

1.  Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth.

Authors:  G Ferraro; B Annibale; M Marignani; C Azzoni; T D'Adda; G D'Ambra; C Bordi; G delle Fave
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.